squirrel-monkey-1335598_960_720

FDA revises methods, after public outrage at testing of monkeys

January 29, 2018
Manufacturing and Production, Medical Communications FDA, biotech, drugs, pharma, pharmaceutical

The story broke in September of last year that the FDA was testing nicotine addiction in squirrel monkeys and that …

accesstoraxone

Santhera’s Raxone rejected in Europe for Duchenne muscular dystrophy

January 29, 2018
Sales and Marketing Duchenne Muscular Dystrophy, EMA, Europe Santhera, pharma

While the EMA’s Committee for Medicinal products for Human Use (CHMP) recommended a spree of treatments over the past week, …

cambridge_biomedical_campus

Delivering the life sciences agenda: Easy as ABC

January 29, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Life sciences strategy, biotech, brexit, drugs, pharma, pharmaceutical

Andrew Blevins and Andrew Carrington of Liberty Property Trust and Countryside Properties explain how organisations at the Cambridge Biomedical Campus …

novartissunlight_copy

Radioactive drug given approval by the FDA

January 29, 2018
Sales and Marketing Advanced Accelerator Applications, Lutathera, Novartis, biotech, drugs, pharma, pharmaceutical

The FDA has approved Lutathera, marking the first time that the agency has given approval for a radioactive drug or …

european_commission_web

EMA committee recommends seven therapies from Roche, GSK, MSD and more

January 29, 2018
Sales and Marketing Biocon, Chiesi, Chugai, GSK, GlaxoSmithKline, MSD, Mylan, Roche, Sanofi, pharma

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has voiced its recommendation of a raft of …

brexit_flag_0

Brexit Health Alliance warns of UK at back of the medicine queue

January 29, 2018
Medical Communications, Sales and Marketing biotech, brexit, drugs, pharma, pharmaceutical

The Brexit Health Alliance (BHA) has cautioned that unless a favourable deal is struck, the UK could end Brexit negotiations …

Sanofi swoops for Ablynx in $4.8bn deal

January 29, 2018
Sales and Marketing Ablynx, Sanofi, biotech, drugs, pharma, pharmaceutical

Sanofi has moved quickly to tie up a deal with Ablynx for $4.8 billion, when it looked more likely that …

pills_in_hand

NICE urges curbing the use of antibiotics for sore throats

January 26, 2018
Medical Communications Antibiotics, NICE, biotech, drugs, pharma, pharmaceutical

In a study published by the BMJ a few years ago, it was found that antibiotics were prescribed in 60% …

AZ’s triple therapy inhaler hits 8 out of 9 endpoints

January 26, 2018
Medical Communications, Research and Development AstraZeneca, COPD, biotech, drugs, pharma, pharmaceutical

AstraZeneca has made a brief announcement that its triple therapy inhaler manage to successfully hit eight of nine primary endpoints …

iQOS heat-not-burn electronic tobacco product doesn’t reduce health risk, FDA says

January 26, 2018
Medical Communications, Sales and Marketing FDA, Philip Morris, iQOS, pharma, smoking, tobacco

An advisory panel of the FDA has judged that US tobacco firm Philip Morris International (PMI) has not been able …

Biogen announces acquisition along with financials, but it’s tiny

January 26, 2018
Medical Communications, Sales and Marketing Biogen, Karyopharm, biotech, drugs, pharma, pharmaceutical

Biogen is one those companies, like Sanofi until its recent Bioverativ acquisition, that has real pressure to make a big …

aging_-_hand

Senescent cell findings provides Parkinson’s treatment clue

January 25, 2018
Research and Development Alzheimer's, biotech, drugs, pharma, pharmaceutical

Senescent cells are the dormant state that cells shift to in response to certain stressors, it is thought that they …

spark_v2

Spark hands over Luxturna rights outside US to Novartis for $170m

January 25, 2018
Sales and Marketing Luxturna, Novartis, Spark Therapeutics, pharma

Novartis has confirmed a deal worth a potential $170 million with Spark Therapeutics to develop and commercialise its gene therapy …

old_man_bar

Amyloid pathway doubts after latest Alzheimer’s failure

January 25, 2018
Research and Development Alzheimer's, biotech, drugs, pharma, pharmaceutical

There has been another drug failure in a large Phase 3 that once again crushes a hope for a possible …

alex_azar_wwsg_photo_cropped

Trump nominee and ex-Lilly exec confirmed as US Health Secretary by Senate

January 25, 2018
Manufacturing and Production, Medical Communications, Sales and Marketing Alex Azar, Eli Lilly, President trump, Trump, US, pharma

Alex Azar, President’s Trump’s controversial pick for Health and Human Services Secretary (HHS), has been confirmed in the role after …

gw_pharma

GW Pharma boasts new positive data, readying for approval

January 25, 2018
Research and Development GW Pharma, biotech, drugs, pharma, pharmaceutical

The latest data from GW Pharma is about as conclusively positive as you can usually hope to get with a …

influenza_dan_higgins_douglas_jordan_uscdcp

New vaccine provides universal protection against influenza A, study finds

January 24, 2018
Research and Development Georgia State University, Vaccine, flu, influenza, pharma

Research led by Georgia State University has enabled the development of a universal vaccine for influenza A viruses, proven to …

shutterstock_92671375

US court upholds ruling that J&J’s Remicade patent is invalid

January 24, 2018
Research and Development, Sales and Marketing J&J, JJ, Johnson & Johnson, Remicade, biosimilars, infliximab, patent, pharma

The US Court of Appeals for the Federal Circuit has judged that Johnson & Johnson’s patent for its best-selling arthritis …

shutterstock_138095450

New York City launches $500 million lawsuit against big pharma over opioid crisis

January 24, 2018
Research and Development, Sales and Marketing New York City, opioid crisis, opioids, pharma

The administration of New York City Mayor Bill de Blasio has announced its intention to bring legal action against the …

The Gateway to Local Adoption Series

Latest content